Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Sees Large Increase in Short Interest

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 524,500 shares, an increase of 99.1% from the March 15th total of 263,500 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 5,245.0 days.

Recordati Industria Chimica e Farmaceutica Stock Performance

Shares of OTCMKTS RCDTF opened at $51.60 on Friday. The company’s 50-day simple moving average is $51.60 and its 200-day simple moving average is $48.15. Recordati Industria Chimica e Farmaceutica has a 52-week low of $51.60 and a 52-week high of $51.98. The company has a current ratio of 1.28, a quick ratio of 0.86 and a debt-to-equity ratio of 0.80.

About Recordati Industria Chimica e Farmaceutica

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.